Table 5 Associations between health outcomes (uLTE4 and albuterol usage) and PM1.5 exposure events (increase of at least 5 or 10 μg/m3 within microenvironment) as measured by the personal monitor
Micro-environment | Exposure event increase | Lag, days | % Increase for exposure event (95 % CI) | |
|---|---|---|---|---|
Albuterol usage | LTE4 | |||
Home | 5μg/m3 | 0 | −1.7 (−17.6, 17.2) | 13.3 (−7.6,39.1) |
1 | 11.0 (−10.1, 37.1) | 7.4 (−16.0,37.2) | ||
0-1 | −1.2 (−17.3, 18.0) | 4.1 (−11.5,22.5) | ||
10μg/m3 | 0 | 10.3 (−6.5, 30.3) | 17.7 (−4.8,45.6) | |
1 | 13.4 (−8.3, 40.2) | −3.4 (−23.4,21.8) | ||
0-1 | 7.6 (−7.6, 25.1) | 9.5 (−8.5,31.2) | ||
Transit | 5μg/m3 | 0 | 9.7 (−5.9, 27.9) | 24.0 (1.5,51.5) |
1 | 17.6 (−6.9, 48.6) | 17.2 (−3.9,43.1) | ||
0-1 | 13.7 (−4.3, 35.2) | 13.2 (−2.8,31.7) | ||
10μg/m3 | 0 | 10.8 (−4.2, 28.2) | 10.9 (−10.4,37.2) | |
1 | 6.3 (−15.5, 33.6) | 8.7 (−12.7,35.2) | ||
0-1 | 7.3 (−9.5, 27.2) | 4.7 (−10.5,22.4) | ||
School | 5μg/m3 | 0 | 13.3 (−5.7, 36.0) | 10.6 (−9.0,34.4) |
1 | 5.9 (−13.2, 29.1) | 2.7 (−16.5,26.4) | ||
0-1 | 1.7 (−14.6, 21.1) | 9.0 (−5.2,25.4) | ||
10μg/m3 | 0 | 12.4 (−5.2, 33.2) | 19.0 (−5.3,49.6) | |
1 | 3.1 (−19.3, 31.6) | 0.6 (−19.8,26.3) | ||
0-1 | 4.8 (−11.6, 24.3) | 9.1 (−6.0,26.6) | ||